000 01476 a2200397 4500
005 20250516165501.0
264 0 _c20131119
008 201311s 0 0 eng d
022 _a1326-5377
024 7 _a10.5694/mja12.11856
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCohen, Neale D
245 0 0 _aThe rationale for combining GLP-1 receptor agonists with basal insulin.
_h[electronic resource]
260 _bThe Medical journal of Australia
_cAug 2013
300 _a246-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEvidence-Based Medicine
650 0 4 _aGlucagon-Like Peptide 1
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xtherapeutic use
650 0 4 _aInsulin, Long-Acting
_xadministration & dosage
650 0 4 _aPrecision Medicine
_xmethods
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTreatment Outcome
700 1 _aAudehm, Ralph
700 1 _aPretorius, Elaine
700 1 _aKaye, Joey
700 1 _aChapman, Leon H
700 1 _aColagiuri, Stephen
773 0 _tThe Medical journal of Australia
_gvol. 199
_gno. 4
_gp. 246-9
856 4 0 _uhttps://doi.org/10.5694/mja12.11856
_zAvailable from publisher's website
999 _c23040723
_d23040723